Share
90.05K people have invested in this fund
90.05K people have invested
in this fund as of
Total AUM
₹881.85 crores as of Oct 31, 2024
Age of Fund
2 years 8 months since Feb 14, 2022
Expense Ratio
1.16% as of Nov 11, 2024 (this includes expense of underlying funds)
Exit Load
Nil
Ideal holding period
10 Years+
Holdings
as of Oct 31, 2024Bluebox Global Technology Fund
35.23%
iShares NASDAQ 100 UCITS ETF
30.66%
KRANESHARES CSI CHINA INTRNT
14.95%
IVZ NASDAQ 100 EW ACC
13.00%
Bluebox Precision Medicine Fund
2.49%
Rolling Returns
Jay Kothari
Prescribed asset allocation:
95% - 100% Units of Innovation Funds
, 0% - 5% Money market securities and/or units of money market/liquid schemes of DSP Mutual Fund
The Scheme intends to invest in following Innovation Funds:
iShares PHLX Semiconductor ETF
BGF World Tech Fund D2 USD
iShares NASDAQ 100 UCITS ETF
Baillie Gifford Worldwide Long term Global growth Fund
Nikko AM ARK Disruptive Innovation Fund
Morgan Stanley US Insight Fund
Bluebox Global Technology Fund
Invesco NASDAQ-100 Equal Weight UCITS ETF
Bluebox Precision Medicine Fund
Fidelity Select Medical Technology and Devices Portfolio
HSBC Hang Seng TECH UCITS ETF
KraneShares CSI China Internet UCITS ETF
Top holdings
Bluebox Global Technology Fund
35.23%
iShares NASDAQ 100 UCITS ETF
30.66%
KRANESHARES CSI CHINA INTRNT
14.95%
IVZ NASDAQ 100 EW ACC
13.00%
Bluebox Precision Medicine Fund
2.49%
Top Sectors
Mutual-funds
Top holdings
No Data to display
Top holdings
TREPS / Reverse Repo Investments
3.89%
Cash & cash equivalents
-0.22%
Instrument break-up
TREPS
100.00%
Performance highlights over last
for
investment
Cumulative returns on
Annual returns
Current value
Good Returns
Negative Returns
vs Category
vs Benchmark
Historical Returns (As per SEBI format)as of with investment of₹10,000
| This fund | MSCI ACWI Net Total Return ^ | NIFTY 50 TRI # | ||||
|---|---|---|---|---|---|---|
| CAGR | Current Value | CAGR | Current Value | CAGR | Current Value | |
Income distribution Cum Capital Withdrawal (IDCW) Distributed
| Record Date | IDCW per unit | NAV Before | NAV After |
|---|
| Funds | Annual returns | Current Value | Absolute Growth |
|---|
Date of allotment: Feb 14, 2022.
Period for which fund's performance has been provided is computed based on last day of the month-end preceding the date of advertisement
Different plans shall have a different expense structure. The performance details provided herein are of Direct Plan.
Since inception returns have been calculated from the date of allotment till June 30, 2021
Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments
Rolling returns have been calculated based on returns from regular plan growth option.
^ Fund Benchmark # Additional Benchmark
The primary investment objective of the scheme is to seek capital appreciation by investing in global mutual fund schemes and ETFs that primarily invest in companies with innovation theme having potential for higher revenue and earnings growth.
The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP Mutual Fund, in order to meet liquidity requirements from time to time.
However, there is no assurance that the investment objective of the Scheme will be realized.
An open ended fund of fund scheme investing in innovation theme.
Level of Risk in the fund
90.05K peoplehave invested in this fund as of
Equity holdings for DSP Global Innovation Fund of Fund
| Name | % of Net Assets |
|---|---|
| Bluebox Global Technology Fund | 35.23% |
| iShares NASDAQ 100 UCITS ETF | 30.66% |
| KRANESHARES CSI CHINA INTRNT | 14.95% |
| IVZ NASDAQ 100 EW ACC | 13.00% |
| Bluebox Precision Medicine Fund | 2.49% |
Debt holdings for DSP Global Innovation Fund of Fund
| Name | % of Net Assets |
|---|---|
| TREPS / Reverse Repo Investments | 3.89% |
100% of Debt instruments
